Abstract:Previous studies suggest that glioma stem cells(GSCs) play important roles in tumoragenesis and development of glioma. It is a promising therapeutic strategy to explore the approach to inhibition of GSCs growth. In this study, we assessed synergistic inhibition effects of ATRA and DAPT on GSCs through the ability of GSCs self-renwal. We examined the inhibition efficiency of GSC-like PGCs growth using trypan blue staining,the ability and efficiency of sphere formation by sphere formation assay under microscope, apoptosis and cell cycle by FACS, and the expression of markers of stem cells through Western blot. The results indicated that ATRA had limited inhibition of PGC1 growth, whereas few effects on PGC2 growth. DAPT obviously inhibited the growth of PGCs compared with ATRA. Furthermore, ATRA(80 μmol/L) induced the differentiation of PGCs, and reduced sphere fromation in size and efficiency by 5%～8% compared with that of control group by 32%～35%. Similarily,DAPT(40 μmol/L) decreased sphere fromation in size and efficiency by 2%～3%. We also found that the ability of self-renwal and stemness was hardly affected in PGCs treated with ATRA(20 μmol/L) or DAPT(5 μmol/L),respectively. On the contrary, combinition of both drugs resulted in decrease in sphere size and sphere formation efficiency by 3%～5%, promoted apoptosis and significantly downregulated the expression of markers of stem cells Nestin, CD133, Sox2, Oct4 and upregualted the expression of GFAP. Our finding confirmed the synergistic inhibition effects of ATRA and DAPT on GSCs self-renwal, which might provide the evidence for further clinical research against glioma stem cells.

Synergistic Inhibition Effects of ATRA and DAPT on the Ability of Self-renewal of Glioma Stem Cells